A high menaquinone intake reduces the incidence of coronary heart disease.
about
Vitamin K for the primary prevention of cardiovascular diseaseSafety and toxicological evaluation of a synthetic vitamin K2, menaquinone-7Vitamin K: the effect on health beyond coagulation - an overviewConcepts and Controversies in Evaluating Vitamin K Status in Population-Based StudiesProper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular HealthThe health benefits of vitamin KEpigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic SyndromeAre there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake.Plasma phylloquinone, menaquinone-4 and menaquinone-7 levels and coronary artery calcificationVitamins K1 and K2: The Emerging Group of Vitamins Required for Human HealthThe molecular biology and pathophysiology of vascular calcification.Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.Liver-specific γ-glutamyl carboxylase-deficient mice display bleeding diathesis and short life span.Development of menaquinone-7 enriched nutraceutical: inside into medium engineering and process modelingYogurt drink fortified with menaquinone-7 improves vitamin K status in a healthy population.Effect of sequential bio-processing conditions on the content and composition of vitamin K2 and isoflavones in fermented soy food.Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).Mechanisms of arterial remodeling: lessons from genetic diseases.The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trialsClinical practice guidelines on postmenopausal osteoporosis: An executive summary and recommendationsThe Role of Vitamin K in Chronic Aging Diseases: Inflammation, Cardiovascular Disease, and Osteoarthritis.Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.Intake of dietary phylloquinone and menaquinones and risk of stroke.Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements.Cheese Consumption and Risk of All-Cause Mortality: A Meta-Analysis of Prospective Studies.Osteoporosis--a risk factor for cardiovascular disease?The role of menaquinones (vitamin K₂) in human health.Vitamin K series: current status and future prospects.Effect of cheese consumption on blood lipids: a systematic review and meta-analysis of randomized controlled trials.Fecal concentrations of bacterially derived vitamin K forms are associated with gut microbiota composition but not plasma or fecal cytokine concentrations in healthy adults.Phylloquinone Intake Is Associated with Cardiac Structure and Function in Adolescents.Production and application of menaquinone-7 (vitamin K2): a new perspective.Reproducibility and relative validity of a food frequency questionnaire to estimate intake of dietary phylloquinone and menaquinones.The relationship between fermented food intake and mortality risk in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort.Dietary intake of vitamin K is inversely associated with mortality risk.Effect of biofilm formation by Bacillus subtilis natto on menaquinone-7 biosynthesis.Strain and plastic composite support (PCS) selection for vitamin K (Menaquinone-7) production in biofilm reactors.Circulating Vitamin K Is Inversely Associated with Incident Cardiovascular Disease Risk among Those Treated for Hypertension in the Health, Aging, and Body Composition Study (Health ABC).Vitamin K deficiency: the linking pin between COPD and cardiovascular diseases?
P2860
Q24187091-659FB647-7B7B-4D3B-BBA1-D1171F3D8768Q24596198-0CF1469D-3A0B-4456-92C4-CE9F579A4937Q24602306-E808DAEA-1A7B-4156-929C-2E2D88F89824Q26771243-06ACA27D-8476-4537-94A5-FE364691189BQ26771939-BA83B10D-E806-456E-AC50-32277797663BQ26782816-7DCAFADA-8397-4021-AE8A-0783531BC3B4Q26801281-AB25D06F-2BED-4A2E-A5C4-F092B5E67C1EQ27002431-43734DD1-E655-4913-86CE-936FBF38E91BQ33749240-4955618F-FA89-4BA7-8CA5-72CE48092B97Q33782223-5E02D76F-CB4A-4949-9156-9B450DA5604CQ33862379-DBE88660-3026-46BA-BA4A-7F87464F3869Q34412941-48661853-39F0-4090-8452-99F7A08D1E3DQ34534951-91CE1BDE-E61C-4074-AC93-1E55B8A1B784Q35092888-B9FEB3E8-3B88-4DEB-82B9-6254E3124CC2Q35901396-BB4E9F10-0B48-4D3B-9DEC-652D63979340Q36177678-8E14A107-69BA-403E-B6BF-7AA07ED294E1Q36289797-429B7ABC-E506-4E96-AEF0-313FD47632BCQ36329772-678742DC-7BE6-49E8-950A-816AD5D6D229Q36463642-0692EF48-A6C6-4453-A8A4-907829AF252CQ36689187-2AEC7A81-EBBE-492C-B3AE-C104F62EEEF6Q37202400-DCE42F6D-A414-4916-8267-4E057C01DA25Q37262329-3E92D918-DDA8-4A77-AC94-C9249FE71B7AQ37278038-77790158-CFF2-4EEA-A4C0-D3F5B4007FD0Q37457640-E047FC39-2371-4CE7-A454-DC68019E85BFQ37616207-53F834D2-4CD0-4918-B993-AB35A1A14978Q37628446-20699393-0261-4329-8B27-F988D790C667Q38034388-0213CF73-D90D-4951-A24D-F1345F126E06Q38099442-5472C0CE-9C24-4F45-8EDE-927CF082514CQ38138614-A1C23756-2F31-439D-ADD6-FA906D3931AEQ38503026-29377405-7FD4-4FBC-95DB-32C39A2B2D42Q38621571-6B581D94-5BC1-4474-9F54-8F2E17A9040CQ38631657-53B1EEDF-D3D6-4CBE-92F6-88F4131A0506Q38796686-12F3F88C-D909-4F78-A8C5-D5618D2A8535Q40081575-77A97D2C-25C9-49EC-98EE-9D2579B44878Q41563248-BEF3EF6C-A864-44E5-B82B-7C47E6F33FC8Q43640767-13CDC75B-BCBC-4680-917F-12C8E5C0C54BQ43748356-77139E93-6009-4AA0-9569-0DDDE2FE933AQ46342012-A901E675-1198-474E-B912-2C7E166BCFE7Q46608099-8881988E-2656-469F-A375-AE641F8736C3Q47112630-13ACB0DD-AE16-4244-BBE4-F2BE80E82F03
P2860
A high menaquinone intake reduces the incidence of coronary heart disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A high menaquinone intake reduces the incidence of coronary heart disease.
@ast
A high menaquinone intake reduces the incidence of coronary heart disease.
@en
A high menaquinone intake reduces the incidence of coronary heart disease.
@nl
type
label
A high menaquinone intake reduces the incidence of coronary heart disease.
@ast
A high menaquinone intake reduces the incidence of coronary heart disease.
@en
A high menaquinone intake reduces the incidence of coronary heart disease.
@nl
prefLabel
A high menaquinone intake reduces the incidence of coronary heart disease.
@ast
A high menaquinone intake reduces the incidence of coronary heart disease.
@en
A high menaquinone intake reduces the incidence of coronary heart disease.
@nl
P2093
P1476
A high menaquinone intake reduces the incidence of coronary heart disease.
@en
P2093
D E Grobbee
G C M Gast
J C Witteman
J M Geleijnse
J W J Beulens
N M de Roos
P H M Peeters
P304
P356
10.1016/J.NUMECD.2008.10.004
P577
2009-01-28T00:00:00Z